23.39
price down icon2.46%   -0.59
after-market Dopo l'orario di chiusura: 23.39
loading
Precedente Chiudi:
$23.98
Aprire:
$23.99
Volume 24 ore:
782.18K
Relative Volume:
0.98
Capitalizzazione di mercato:
$2.63B
Reddito:
$14.09M
Utile/perdita netta:
$-176.94M
Rapporto P/E:
-10.88
EPS:
-2.15
Flusso di cassa netto:
$-141.24M
1 W Prestazione:
+6.41%
1M Prestazione:
+27.12%
6M Prestazione:
-0.89%
1 anno Prestazione:
+23.82%
Intervallo 1D:
Value
$22.88
$24.06
Intervallo di 1 settimana:
Value
$21.75
$24.18
Portata 52W:
Value
$14.06
$27.29

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
Nome
Newamsterdam Pharma Company Nv
Name
Telefono
35 206 2971
Name
Indirizzo
GOOIMEER 2-35, NARRDEN
Name
Dipendente
77
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
NAMS's Discussions on Twitter

Confronta NAMS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NAMS
Newamsterdam Pharma Company Nv
23.39 2.69B 14.09M -176.94M -141.24M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-17 Iniziato Goldman Neutral
2025-06-17 Iniziato Citigroup Buy
2025-06-10 Iniziato Stifel Buy
2025-06-04 Iniziato Cantor Fitzgerald Overweight
2024-12-30 Iniziato H.C. Wainwright Buy
2024-05-15 Iniziato TD Cowen Buy
2024-03-14 Iniziato Scotiabank Sector Outperform
2024-01-18 Iniziato Guggenheim Buy
2024-01-16 Iniziato Piper Sandler Overweight
2023-10-30 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie

pulisher
Jul 24, 2025

Will NewAmsterdam Pharma Company N.V. Equity Warrant stock split in the near futureUnmatched market gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about NewAmsterdam Pharma Company N.V. Equity Warrant stockRobust investment performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Arizona State Retirement System Buys New Shares in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about NewAmsterdam Pharma Company N.V. stockFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. stock priceRapid wealth creation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What makes NewAmsterdam Pharma Company N.V. stock price move sharplyDaily Breakout Picks - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant Stock Analysis and ForecastHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma Company N.V. Stock Analysis and ForecastDouble-digit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Major Alzheimer's Discovery: Cardiovascular Drug Shows Promising Brain Health Benefits in 1,727 Patients - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NewAmsterdam Pharma Company N.V. Equity Warrant stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs during market volatilityFree High-Profit Stock Picks - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Is NewAmsterdam Pharma Company N.V. Equity Warrant a good long term investmentExceptional return forecasts - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is NewAmsterdam Pharma Company N.V. a good long term investmentExplosive portfolio gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

why newamsterdam pharma company n.v. equity warrant stock attracts strong analyst attentionFree Risk Assessment Services - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

When is the best time to buy NewAmsterdam Pharma Company N.V. stockFree Access to Investment Community - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated at The Goldman Sachs Group - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

How NewAmsterdam Pharma Company N.V. stock reacts to Fed policy changesFree Capital Allocation Plans - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Goldman Sachs Initiates Coverage on NewAmsterdam Pharma With Neutral Rating, $27 Price Target - MarketScreener

Jul 17, 2025
pulisher
Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Goldman Sachs initiates NewAmsterdam Pharma stock with Neutral rating - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives $42.89 Consensus Price Target from Analysts - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Jefferies Remains Bullish on NewAmsterdam Pharma (NAMS) - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey

Jul 16, 2025
pulisher
Jul 16, 2025

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts strong analyst attentionWatchlist Winner Update - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why NewAmsterdam Pharma Company N.V. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How NewAmsterdam Pharma Company N.V. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025

Newamsterdam Pharma Company Nv Azioni (NAMS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):